Biblio

Export 2657 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is S  [Clear All Filters]
2015
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein., J Alzheimers Dis, 2015.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein., J Alzheimers Dis, 2015.
H. Bielarczyk, Jankowska-Kulawy, A., Hofling, C., Ronowska, A., Gul-Hinc, S., Rossner, S., Schliebs, R., Pawelczyk, T., and Szutowicz, A., AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease., J Alzheimers Dis, 2015.
H. Bielarczyk, Jankowska-Kulawy, A., Hofling, C., Ronowska, A., Gul-Hinc, S., Rossner, S., Schliebs, R., Pawelczyk, T., and Szutowicz, A., AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease., J Alzheimers Dis, 2015.
N. Voyle, Baker, D., Burnham, S. C., Covin, A., Zhang, Z., Sangurdekar, D. P., Hehir, C. A. Tan, Bazenet, C., Lovestone, S., Kiddle, S., and Dobson, R. J. B., Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology., J Alzheimers Dis, 2015.
J. Olazarán, Gil-de-Gómez, L., Rodríguez-Martín, A., Valentí-Soler, M., Frades-Payo, B., Marín-Muñoz, J., Antúnez, C., Frank-García, A., Jiménez, C. Acedo, Gracia, L. Morlén, Torregrossa, R. Petidier, Guisasola, M. Concepció, Bermejo-Pareja, F., Sánchez-Ferro, Á., Pérez-Martínez, D. A., Palomo, S. Manzano, Farquhar, R., Rábano, A., and Calero, M., A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease., J Alzheimers Dis, 2015.
H. Jang, Kim, J. Hun, Choi, S. Hye, Lee, Y., Hong, C. Hyung, Jeong, J. Hyang, Han, H. Jeong, Moon, S. Young, Park, K. Won, Han, S. - H., Park, K. Hyung, Kim, H. Jin, Na, D. L., and Seo, S. Won, Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease., J Alzheimers Dis, 2015.
K. Matsuzono, Yamashita, T., Ohta, Y., Hishikawa, N., Sato, K., Kono, S., Deguchi, K., Nakano, Y., and Abe, K., Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS)., J Alzheimers Dis, vol. 46, no. 3, pp. 687-93, 2015.
C. E. Gleason, Fischer, B. L., N Dowling, M., Setchell, K. D. R., Atwood, C. S., Carlsson, C. M., and Asthana, S., Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 47, no. 4, pp. 1009-19, 2015.
D. Kelly, Coen, R. F., Akuffo, K. Owusu, Beatty, S., Dennison, J., Moran, R., Stack, J., Howard, A. N., Mulcahy, R., and Nolan, J. M., Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids., J Alzheimers Dis, vol. 48, no. 1, pp. 261-77, 2015.
H. Liu-Seifert, Siemers, E., Price, K., Han, B., Selzler, K. J., Henley, D., Sundell, K., Aisen, P., Cummings, J., Raskin, J., and Mohs, R., Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease., J Alzheimers Dis, vol. 47, no. 1, pp. 205-14, 2015.
H. Liu-Seifert, Siemers, E., Price, K., Han, B., Selzler, K. J., Henley, D., Sundell, K., Aisen, P., Cummings, J., Raskin, J., and Mohs, R., Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease., J Alzheimers Dis, vol. 47, no. 1, pp. 205-14, 2015.
H. Liu-Seifert, Siemers, E., Price, K., Han, B., Selzler, K. J., Henley, D., Sundell, K., Aisen, P., Cummings, J., Raskin, J., and Mohs, R., Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease., J Alzheimers Dis, vol. 47, no. 1, pp. 205-14, 2015.
K. Nho, Ramanan, V. K., Horgusluoglu, E., Kim, S., Inlow, M. H., Risacher, S. L., McDonald, B. C., Farlow, M. R., Foroud, T. M., Gao, S., Callahan, C. M., Hendrie, H. C., Niculescu, A. B., and Saykin, A. J., Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults., J Alzheimers Dis, 2015.
E. Coart, Barrado, L. García, Duits, F. H., Scheltens, P., van der Flier, W. M., Teunissen, C. E., van der Vies, S. M., and Burzykowski, T., Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease., J Alzheimers Dis, 2015.
L. Calderón-Garcidueñas, Mora-Tiscareño, A., Sánchez, G. Melo, Rodríguez-Díaz, J., Torres-Jardón, R., Styner, M., Mukherjee, P. S., Lin, W., and Jewells, V., A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents., J Alzheimers Dis, 2015.
L. Calderón-Garcidueñas, Mora-Tiscareño, A., Sánchez, G. Melo, Rodríguez-Díaz, J., Torres-Jardón, R., Styner, M., Mukherjee, P. S., Lin, W., and Jewells, V., A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents., J Alzheimers Dis, 2015.
N. J. Donovan, Hsu, D. C., Dagley, A. S., Schultz, A. P., Amariglio, R. E., Mormino, E. C., Okereke, O. I., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A., Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults., J Alzheimers Dis, 2015.
N. J. Donovan, Hsu, D. C., Dagley, A. S., Schultz, A. P., Amariglio, R. E., Mormino, E. C., Okereke, O. I., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A., Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults., J Alzheimers Dis, 2015.
E. Moyse, Bastin, C., Salmon, E., and Brédart, S., Impairment of Age Estimation from Faces in Alzheimer's Disease., J Alzheimers Dis, 2015.
N. Kemppainen, Joutsa, J., Johansson, J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R., and Rinne, J. O., Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment., J Alzheimers Dis, vol. 48, no. 1, pp. 123-33, 2015.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease., J Alzheimers Dis, 2015.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease., J Alzheimers Dis, 2015.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease., J Alzheimers Dis, 2015.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., sAβPPα is a Potent Endogenous Inhibitor of BACE1., J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.

Pages